CCM
BEAT

Copernicus Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Copernicus Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-70,000
Closed -$2.09M – 30
2017
Q4 		$2.09M Buy
+70,000
New +$2.03M 1.56% 23

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Copernicus Capital Management's BEAT Position: Q1 2018 in Review

Copernicus Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2018, closing a stake of 70,000 shares — an estimated $2.09M sold.

Copernicus Capital Management first reported a position in BEAT in Q4 2017 and held it in 1 quarter. The position peaked at $2.09M in Q4 2017. 202 funds tracked by Wall St. Rank hold BEAT as of Q1 2018.

  • Copernicus Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2018 after selling out during the quarter.
  • Copernicus Capital Management sold 70,000 BioTelemetry, Inc. shares in Q1 2018, an estimated $2.09M.
  • Copernicus Capital Management first reported a position in BioTelemetry, Inc. in Q4 2017 and held it in 1 quarter.
  • Copernicus Capital Management's BioTelemetry, Inc. position peaked at $2.09M in Q4 2017.
  • 202 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2018.

Based on Copernicus Capital Management's 13F filing for Q1 2018, filed 1 May 2018.